Home Epigenetics Histone Methyltransferase inhibitor - COMT inhibitor Entacapone For research use only.

Entacapone

Synonyms: OR-611

Entacapone (OR-611) inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM. Entacapone can be used for the research of Parkinson's disease. Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders.

Entacapone Chemical Structure

Entacapone Chemical Structure

CAS: 130929-57-6

Selleck's Entacapone has been cited by 2 publications

Purity & Quality Control

Batch: S314701 DMSO] 61 mg/mL] false] Ethanol] 2 mg/mL] false] Water] Insoluble] false Purity: 99.98%
99.98

Entacapone Related Products

Signaling Pathway

Histone Methyltransferase Signaling Pathways

Histone Methyltransferase Signaling Pathway

Choose Selective Histone Methyltransferase Inhibitors

Biological Activity

Description Entacapone (OR-611) inhibits catechol-O-methyltransferase(COMT) with IC50 of 151 nM. Entacapone can be used for the research of Parkinson's disease. Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders.
Targets
COMT [1]
151 nM
In vitro
In vitro

Entacapone inhibits catechol-O-methyltransferase(COMT) with similar IC50 in different tissues including live, duodenum, kidney and lung, but entacapone is more active than tolcapone in those tissues. [1]

Entacapone (< 100 μM) is a potent inhibitor of α-syn and β-amyloid (Aβ) oligomerization and fibrillogenesis, and also protects against extracellular toxicity induced by the aggregation of both proteins in PC12 cells. [2]
Cell Research Cell lines PC12 cells
Concentrations 5 μM
Incubation Time 72 h
Method

Cells were treated with various concentrations of drug for 72 h.
In Vivo
In vivo

Entacapone administration reduced body weight and lowered fasting blood glucose concentrations in diet-induced obese mice.
Animal Research Animal Models Male C57BL/6 mice
Dosages 600 mg/kg
Administration p.o.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02058966 Completed
Methamphetamine Dependence
Oregon Health and Science University|Portland VA Medical Center
 June 2014 Early Phase 1
NCT00547911 Terminated
Parkinson Disease|Multiple System Atrophy|Autonomic Nervous System Diseases
National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC)
 October 2007 Phase 1|Phase 2
NCT00415922 Completed
Healthy
Novartis
 July 2006 Phase 1
NCT00415831 Completed
Healthy
Novartis
 June 2006 Phase 1
NCT00415844 Completed
Healthy
Novartis
 June 2006 Phase 1

Chemical Information & Solubility

Molecular Weight 305.29 Formula

C14H15N3O5
CAS No. 130929-57-6 SDF Download Entacapone SDF
Smiles CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 61 mg/mL ( (199.81 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 2 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Entacapone | Entacapone supplier | purchase Entacapone | Entacapone cost | Entacapone manufacturer | order Entacapone | Entacapone distributor